| Literature DB >> 35564421 |
Izabela Winkler1,2, Ilona Jaszczuk3, Marek Gogacz2, Piotr Szkodziak4, Tomasz Paszkowski4, Katarzyna Skorupska2, Michał Ciebiera5, Maciej Skrzypczak2.
Abstract
BACKGROUND: The aim of the present study is to report a rare occurrence of a successful twin pregnancy in a woman with pure 46,XY gonadal dysgenesis. RESULT(S): A patient with Swyer syndrome (pure 46,XY gonadal dysgenesis) presented with a twin pregnancy after in vitro fertilization. Due to unidentified conditions, the patient developed selective intrauterine growth restriction in one of the fetuses. Twins were born at 33 weeks of pregnancy due to the risk of asphyxia. Nonetheless, the patient did not develop gonadal malignancies before the pregnancy and, despite receiving estrogen, remained amenorrheic. CONCLUSION(S): The aim of this case report is to show the course of twin pregnancy in patients with Swyer syndrome through assisted reproduction. Due to certain disorders in the development of their reproductive organs, such as the less mature uterus, such pregnancies may be associated with an increased risk. The above case report demonstrates the need to systematize methods of pregnancy management in patients with Swyer syndrome, such as: preparation for the pregnancy, assessment of the uterus, medications used, and necessary checkups. Capsule: This case report and review shows clinicians that patients with Swyer syndrome may become pregnant. Twin pregnancies may occur without any major problems through assisted reproduction.Entities:
Keywords: Swyer syndrome; pure gonadal dysgenesis; twin pregnancy
Mesh:
Year: 2022 PMID: 35564421 PMCID: PMC9100276 DOI: 10.3390/ijerph19095027
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Pharmacotherapy in the presented case.
| Parameter | I Trimester | II Trimester | III Trimester |
|---|---|---|---|
| Estrofem (estradiol) orally | 2 mg + 2 mg + 2 mg | 2 mg + 0 + 2 mg | 1 mg + 0 + 1 mg |
| Progesterone Prolutex (progesterone) Progesterone 200 mg intravaginally | |||
| Encorton (prednisone) | 5 mg | 5 mg | 2.5 mg |
| Aspirin (acetylsalicylic acid) | 150 mg | 150 mg | 150 mg until its discontinuation at week 32 |
| Other drugs | Pimafucin (Natamycin 100 mg) 1 × 1 tablet intravaginally for 6 days | Monural (fosfomycin 3 g) orally | Essentiale forte (phospholipids 300 mg − 1 tablet) 3 × 2 tablets |
Figure 1Mini-hysteroscopy view in the patient with Swyer syndrome.
Figure 2USG scan of twin pregnancy (dichorionic diamniotic—7 week of pregnancy) in patient with Swyer syndrome.
First trimester scan.
| Parameter | Twin 1 | Twin 2 |
|---|---|---|
|
|
| |
| CRL(crown–rump length) (mm) | 49.2–11w5d | 51.30–11w6 |
| BPD (biparietal diameter) (mm) | 14.5–12w0 | 17.2–12w4d |
| FHR/min (fetal heart rate) | 160 | 161 |
| NT (mm) (nuchal translucency) | 1.42 | 1.2 |
Ultrasound growth patterns in the second and third trimesters.
| Parameter | Twin 1 in Trimester II | Twin 2 in Trimester II | Twin 1 in Trimester III | Twin 2 in Trimester III |
|---|---|---|---|---|
| BPD (mm) (biparietal diameter) | 58.7–23w1d | 57–22w5d | 76.4–29w3d | 75.3–29w0d |
| HC (mm) (head circumference) | 221–24w1d | 207–22w6d | 275.3–29w3d | 261–27w6d |
| FL (femur length) (mm) | 40.8 mm–23w1d | 37.6–22w0 | 54.9–29w2d | 51.6–27w5 |
| AC (abdominal circumference) (mm) | 180 | 174 | 240 | 221.5 |
| AFI (amniotic fluid) | normal | normal | normal | normal |
| FHR/min (fetal heart rate) | 153 | 160 | 150 | 148 |
| EFW (g) (estimated fetal weight) | 570 | 493 | 1298 | 1057 |
| EFW discrepancy | 13.5% (assessment at 22 weeks 6 days) | 18.6% (assessment at 28 weeks 0 days) | ||
Figure 3Ultrasound parameters of the first twin’s well-being: (A) assessment of blood flow in the MCA; (B) assessment of blood flow in the UA; (C) amniotic fluid index [6,7].
Figure 4Ultrasound parameters of the second twin’s well-being: (A) assessment of blood flow in the MCA; (B) assessment of blood flow in the UA; (C) amniotic fluid index [6,7].
Figure 5CTG recordings showed prolonged deceleration of both twins, lasting 7 minutes, and a decrease in the heart rate of both fetuses to 80 beats/minute (FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography, 2015).
Cases of pregnancies in patients with Swyer syndrome.
| Authors | Individuals | Age at Delivery | Pregnancy | Mode of Delivery | Week at Delivery | Complications |
|---|---|---|---|---|---|---|
| Taneja et al., 2014 [ | 1 | 39 | single | cesarean delivery | 39 | pre-eclampsia |
| Selvaraj et al., 2002 [ | 1 | 27 | single | cesarean delivery | not known | none |
| Lutjen P. 1984 [ | 1 | 25 | single | cesarean delivery | 38 | none |
| Cornet et al., 1990 [ | 1 | 25 | single | cesarean delivery | 36-41 | none |
| Bardeguez et al., 1990 [ | 1 | unknown | triplet | cesarean delivery | Unknown | unknown |
| Bianco et al., 1992 [ | 1 | unknown | single | not known | Unknown | unknown |
| Kan et al., 1997 [ | 2 | 30, 32 ( the same woman, two attempts) | 1. single | 1. vaginal delivery | 1. >37 | 1. pre-eclampsia |
| Sauer et al., 1989 [ | 1 | 28 | twin | cesarean delivery | 35 | pregnancy-induced hypertension |
| Ko et al., 2007 [ | 1 | 35 | triplet (twins alive, boy and girl) | cesarean delivery | 33 | pre-eclampsia |
| Dirnfeld et al., 2000 [ | 2 | 30 (the same woman, two attempts) | 1. single | cesarean delivery (both) | 1. 41 | 1. spontaneous demise of one fetus occurred at 19 weeks of pregnancy |
| Plante and Fritz et al., 2008 [ | 1 | 27 | single | cesarean delivery | 38 | none |
| Tulic et al., 2011 [ | 1 | 30 | single | cesarean delivery | 39 | reduced amniotic fluid |
| Chen et al., 2005 [ | 1 | 31 | twin | cesarean delivery | 36 | none |
| Frydman et al., 1988 [ | 1 | 37 | single | cesarean delivery | 41 | none |
| Michala et al., 2008 [ | 3 | unknown | single | 1 and 2 vaginal deliveries | 1, 2. unknown | 1, 2. none |
| Creatsas et al., 2011 [ | 1 | 35 | single | cesarean delivery | 38 | oligohydramnios and abdominal circumference below the 5th percentile |
| De Santis et al., 2013 [ | 1 | 27 | twin | cesarean delivery | 35 | none |
| Gao et al., 2011 [ | 1 | 32 | twin | cesarean delivery | Unknown | none |
| Murtinger et al., 2013 [ | 1 | 30 | twin | cesarean delivery | 36 | none |
| Kalra et al., 2016 [ | 1 | 27 | single | cesarean delivery | 34 | severe pre-eclampsia |
| Shah et al., 2018 [ | 1 | 32 | twin | cesarean delivery | 34 | hypertension |
| Urban et al. [ | 2 | 32,34 | single | cesarean delivery | 40, 39 | no medical evidence of uterine dilatation efficacy |
| Gupta et al. [ | 2 | 25, unknown(younger)—two sisters | Single, single | Details not known | Details not known | Details not known |